Infectious Disease Research Institute

Site of IDRI's facility in the Eastlake neighborhood of Seattle

The Infectious Disease Research Institute (IDRI) is a non-profit organization based in Seattle, in the United States, and which conducts global health research on infectious diseases.

History

IDRI was founded in 1993.[1]

Malaria vaccine

IDRI is collaborating with the United States Agency for International Development to develop a malaria vaccine with the Walter Reed Army Institute of Research using Walter Reed's CelTOS malaria antigen in conjunction with IDRI's GLA-SE adjuvant.[2]

Visceral leishmaniasis vaccine

On February 2012, IDRI launched the world’s first clinical trial of the visceral leishmaniasis vaccine. The vaccine is a recombinant form of two fused Leishmania parasite proteins with an adjuvant. Two phase 1 clinical trials with healthy volunteers are to be conducted. The first one takes place in Washington and is followed by a trial in India. The trials are funded by the Bill & Melinda Gates Foundation.[3]

References

  1. ↑ http://www.idri.org/about.html
  2. ↑ Erica Teichert (18 August 2011). "USAID, IDRI form malaria vax collaboration". fiercevaccines.com. Retrieved 12 September 2011.
  3. ↑ Elvidge, Suzanne (February 23, 2012). "World’s first kala azar vaccine enters the clinic". FierceVaccines.com. Retrieved March 1, 2012.

External links

Official website

Coordinates: 47°38′3.1″N 122°19′28.7″W / 47.634194°N 122.324639°W